Quick Overview: Eric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, ... Dr. Katherine High is Emeritus Professor of Pediatrics at the Perelman School of Medicine of the University of Pennsylvania and ... In this episode of “Intention to Treat,” host Rachel Gotbaum explores the story of a teenager who's now in remission from ...

Nejm At Aha Crispr Cas9 - Detailed Overview & Context

Eric Rubin is the Editor-in-Chief of the Journal. Jane Leopold is a Deputy Editor of the Journal. Stephen Morrissey, the interviewer, ... Dr. Katherine High is Emeritus Professor of Pediatrics at the Perelman School of Medicine of the University of Pennsylvania and ... In this episode of “Intention to Treat,” host Rachel Gotbaum explores the story of a teenager who's now in remission from ... Dr. Matthew H. Porteus, the interviewee, is professor of pediatrics–stem cell transplantation at Stanford University. Stephen ... A virtual workshop for precise HDR-mediated genome engineering with Kevin M. Alexander, MD discusses the results of "First-in-Human in vivo

Dr. Peter Campbell is head of cancer, aging, and somatic mutation, senior group leader, and joint head of the Cancer Genome ... Dr. Evan Eichler is Professor of Genome Sciences at the University of Washington. Stephen Morrissey, the interviewer, is the ... Seattle Science Foundation is a non-profit organization dedicated to the international ... Recently Intellia Therapeutics in collaboration with Regeneron announced some promising results for their phase I trial using their ... Dr. Kevin Schulman is a professor of medicine and of business administration at Duke University. Stephen Morrissey, the ... New England Journal of Medicine, August 5, 2021 presents another example of gene editing for autosomal dominant conditions ...

Dr. Arthur A. Levin, the interviewee, is the Executive Vice President of Research and Development at Avidity Biosciences. Stephen ...

Photo Gallery

NEJM at AHA — CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy
NEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon Disease
NEJM Interview: Dr. Katherine A. High on gene therapy for genetic disease.
Unleashing CRISPR on Cancer
CRISPR Explained
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia CTX001 on NEJM
NEJM Interview: Dr. Matthew H. Porteus on therapeutic editing of the human genome.
A virtual workshop for precise HDR-mediated genome engineering with CRISPR-Cas9
CRISPR Results
AHA 22: Results of the CRISPR-Cas9 First-in-Human Trial
NEJM Interview: Dr. Peter J. Campbell on genome sequencing in cancer.
Jennifer Doudna (UC Berkeley / HHMI): Genome Engineering with CRISPR-Cas9
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored